反应详情

To a stirred solution of N-tert-butyl-2-(6-fluoro-1H-indazol-1-yl)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (101 mg, 209 μmol) in dichloromethane (3 mL) was added trifluoroacetic acid (1 mL). After 15 h, the mixture was concentrated in vacuo then 25 mL of a Jan. 10, 1960 mixture of ammonium hydroxide/methanol/dichloromethane added. After 1 h the mixture was concentrated in vacuo. Purification by chromatography (silica, 24 g Analogix column, 0-4% methanol containing 10% ammonium hydroxide in dichloromethane) gave 2-(6-Fluoro-indazol-1-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide (31 mg, 42%). MS (M+H)+=351; 1H NMR (DMSO-d6) δ: 9.02 (s, 1H), 8.56 (d, J=1.0 Hz, 1H), 8.42 (s, 1H), 8.32 (dd, J=9.4, 2.1 Hz, 1H), 8.02 (dd, J=8.8, 5.3 Hz, 1H), 7.58 (s, 1H), 7.28 (d, J=2.3 Hz, 1H), 1.50 (s, 9H).

1. concentrationthe mixture was concentrated in vacuo
2. addition10, 1960 mixture of ammonium hydroxide/methanol/dichloromethane
3. additionadded
4. concentrationAfter 1 h the mixture was concentrated in vacuo
5. customPurification by chromatography (silica, 24 g Analogix column, 0-4% methanol containing 10% ammonium hydroxide in dichloromethane)